Perrigo Company plc Number of Foreign Currency Derivatives Held
Perrigo Company plc (PRGO) had Number of Foreign Currency Derivatives Held of 2 derivative as of 2021-09-30, per its 10-Q filed 2022-05-11.
Discontinued › Notes › Derivative Instruments and Hedging Activities › Summary of Derivative Instruments by Risk Exposure › Foreign Currency Derivatives
us-gaap:NumberOfForeignCurrencyDerivativesHeld · last filed 2022-05-11
- 2021-09-30: Number of Foreign Currency Derivatives Held 2.00 derivative.
| Period end | Number of Foreign Currency Derivatives Held |
|---|---|
| 2021-09-30 | 2.00 derivative 10-Q · filed 2022-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |